In this study, we found that METTL14 functions as a tumor suppressor in ccRCC metastasis using patients’ samples from our own cohort and a ccRCC tissue microarray, as well as in vitro and in vivo experiments. Here, METTL14 is linked to nonpapillary renal cell carcinoma.